Perinatal COVID-19 maternal and neonatal outcomes at two academic birth hospitals

Objective Describe 1-month outcomes among newborns of persons with perinatal COVID-19. Study design Prospective observational study of pregnant persons who tested positive for SARS-CoV-2 between 14 days before and 3 days after delivery and their newborns, from 3/2020 to 3/2021 at two urban high-risk academic hospitals. Phone interviews were conducted to determine 1-month newborn outcomes. Results Among 9748 pregnant persons, 209 (2.1%) tested positive for perinatal SARS-CoV-2. Symptomatically infected persons were more likely to have a preterm delivery due to worsening maternal condition and their newborns were more likely to test positive for SARS-CoV-2 compared with asymptomatic persons. Six of 191 (3.1%) infants tested were positive for SARS-CoV-2; none had attributable illness before discharge. Of 169 eligible families, 132 (78.1%) participated in post-discharge interviews; none reported their newborn tested positive for SARS-CoV-2 by 1 month of age. Conclusion Symptomatic perinatal COVID-19 had a substantial effect on maternal health but no apparent short-term effect on newborns.

Automated summary

This study describes the 1-month outcomes of newborns born to persons with perinatal COVID-19. The results showed that symptomatic pregnant persons were more likely to have a preterm delivery and their newborns were more likely to test positive for SARS-CoV-2. However, none of the newborns tested positive for SARS-CoV-2 within 1 month after discharge.